1
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Condition(s):Heart FailureLast Updated:December 31, 2020Active, not recruiting
Empagliflozin: 261 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
Effect of Empagliflozin on Liver Fat in Non-diabetic Patients
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:November 24, 2020Not yet recruiting
3
Empagliflozin in Post-Transplantation Diabetes Mellitus
Condition(s):Posttransplant Diabetes MellitusLast Updated:May 7, 2019Completed
4
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
Condition(s):Diabetic NephropathiesLast Updated:December 17, 2020Terminated
5
Empagliflozin and Renal Oxygenation in Healthy Volunteers
Condition(s):NephropathyLast Updated:July 30, 2019Completed
6
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
Condition(s):Type 2 Diabetes MellitusLast Updated:June 16, 2020Not yet recruiting
7
Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
Condition(s):Diabetes Mellitus Type 2Last Updated:May 15, 2018Completed
8
Empagliflozin and Atrial Fibrillation Treatment
Condition(s):Atrial Fibrillation; Heart Failure; Obesity; Diabetes MellitusLast Updated:October 14, 2020Not yet recruiting
9
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:August 15, 2019Completed
10
Effect of Empagliflozin on Ventricular Repolarization.
Condition(s):Diabetes Mellitus, Type 2; Coronary Heart Disease; Arrythmia, CardiacLast Updated:April 7, 2020Recruiting